Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Debt Ratio (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Debt Ratio for 7 consecutive years, with 0.0 as the latest value for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 75.92% to 0.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0, a 75.92% decrease, with the full-year FY2025 number at 0.0, down 75.92% from a year prior.
  • Debt Ratio was 0.0 for Q4 2025 at Beam Therapeutics, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.11 in Q1 2021 to a low of 0.0 in Q3 2025.
  • A 5-year average of 0.02 and a median of 0.01 in 2023 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: skyrocketed 224.01% in 2021, then plummeted 87.91% in 2022.
  • Beam Therapeutics' Debt Ratio stood at 0.03 in 2021, then crashed by 52.34% to 0.01 in 2022, then tumbled by 45.75% to 0.01 in 2023, then rose by 2.85% to 0.01 in 2024, then crashed by 75.92% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for BEAM's Debt Ratio are 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025).